Burg Simpson shareholder Melanie Bailey is a highly-skilled and experienced attorney who is committed to protecting the best interests of those who have been harmed by the negligence of another party. A dedicated advocate for her clients, Melanie fights to maximize financial recoveries, and provide her clients with the best possible outcome to their legal matters.
Melanie Bailey is a member of the firm’s Cincinnati office and practices in the areas of complex civil litigation, pharmaceutical and general products liability, multi-district litigation, personal injury, wrongful death, and class action litigation. During her tenure at Burg Simpson, Ms. Bailey has devoted time to working on pharmaceutical cases, such as Ortho Evra, contaminated Heparin, Yasmin/Yaz, and Depakote. She has also litigated several product liability cases for defective medical devices, such as hip replacements and knee replacements. Melanie is currently handling a class action lawsuit against Ambetter Insurance, and is investigating consumer based claims regarding multiple complaints about the insufficiency of their insurance plans
Prior to joining Burg Simpson Eldredge Hersh & Jardine, P.C., Melanie worked for law firms in Kentucky and Ohio, practicing in the areas of complex civil litigation and class action litigation. In 2006, she was court appointed Class Counsel in a class action employment case on behalf of Wal-Mart employees in the state of Kentucky.
Melanie S. Bailey earned a Bachelor of Arts Degree from Northern Kentucky University, cum laude, and a Juris Doctorate Degree from Salmon P. Chase College of Law, cum laude.
Publications & Media
Cincinnati WCPO, Cincy Lifestyles Interview December 2, 2019
Cincinnati WCPO, Cincy Lifestyles Interview August 5, 2019
Bailey, Melanie S. Recall of IntraClude Device Used In Patients Undergoing Cardiopulmonary Bypass. www.burgsimpson.com, July 2, 2019.
Bailey, Melanie S. Sixth Circuit Court Of Appeals Upholds Trial Verdict In Favor Of Employees For Violations Of The Fair Labor Standards Act. www.burgsimpson.com, May 7, 2019.
Brand Name Drug or Generic Drug - Generic May Foil Your Client's Failure to Warn Case - Cincinnati Bar Association, January/February 2019